<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Treatment recommendations for endemic Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) in settings with only minimum requirements for curative treatment (PODC setting 1) are described </plain></SENT>
<SENT sid="1" pm="."><plain>The reported cure rate for endemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> is usually &lt;50% </plain></SENT>
<SENT sid="2" pm="."><plain>Facilities within setting 1 differ </plain></SENT>
<SENT sid="3" pm="."><plain>Three treatment schedules are proposed based on: (1) when accurate staging is not possible, (2) when staging is possible and for (3) relapses and poor responders to primary therapy </plain></SENT>
<SENT sid="4" pm="."><plain>A literature review and personal experience were used to formulate the recommendations </plain></SENT>
<SENT sid="5" pm="."><plain>Recorded 1-year event free survival was 48% for treatment 1, 61% for treatment 2, and 35% for the rescue treatment </plain></SENT>
</text></document>